Plexus Corp. (NASDAQ:PLXS) Insider Steven J. Frisch Sells 3,567 Shares

Plexus Corp. (NASDAQ:PLXSGet Free Report) insider Steven J. Frisch sold 3,567 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $97.10, for a total transaction of $346,355.70. Following the completion of the sale, the insider now directly owns 65,212 shares of the company’s stock, valued at $6,332,085.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Plexus Trading Down 0.0 %

Shares of NASDAQ PLXS opened at $94.31 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 0.62 and a debt-to-equity ratio of 0.15. Plexus Corp. has a one year low of $83.84 and a one year high of $114.06. The business has a 50-day moving average price of $102.68 and a two-hundred day moving average price of $98.93. The firm has a market capitalization of $2.59 billion, a PE ratio of 21.00 and a beta of 1.05.

Plexus (NASDAQ:PLXSGet Free Report) last posted its quarterly earnings results on Thursday, January 25th. The technology company reported $1.04 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.01). The company had revenue of $982.61 million for the quarter, compared to analyst estimates of $982.57 million. Plexus had a return on equity of 12.16% and a net margin of 3.08%. The business’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.49 earnings per share. As a group, analysts predict that Plexus Corp. will post 4.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have commented on PLXS shares. Benchmark reaffirmed a “buy” rating and set a $110.00 price objective on shares of Plexus in a research note on Wednesday, January 17th. Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price target for the company. in a research report on Tuesday, January 9th. Finally, Needham & Company LLC lowered their price objective on shares of Plexus from $110.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday, January 25th.

View Our Latest Stock Report on Plexus

Institutional Investors Weigh In On Plexus

Institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC acquired a new stake in shares of Plexus during the 4th quarter valued at $44,000. Cetera Trust Company N.A acquired a new stake in shares of Plexus during the 4th quarter valued at $54,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Plexus during the 4th quarter valued at $66,000. Tower Research Capital LLC TRC boosted its stake in shares of Plexus by 680.8% during the 1st quarter. Tower Research Capital LLC TRC now owns 773 shares of the technology company’s stock valued at $75,000 after buying an additional 674 shares during the period. Finally, UBS Group AG boosted its stake in shares of Plexus by 294.9% during the 3rd quarter. UBS Group AG now owns 924 shares of the technology company’s stock valued at $81,000 after buying an additional 690 shares during the period. Institutional investors and hedge funds own 92.91% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Stories

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.